These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 37052841

  • 1. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
    Yang R, Zhang GGZ, Zemlyanov DY, Purohit HS, Taylor LS.
    Pharm Res; 2023 Dec; 40(12):2817-2845. PubMed ID: 37052841
    [Abstract] [Full Text] [Related]

  • 2. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS, Lou X, Zhang GGZ, Taylor LS.
    Mol Pharm; 2019 Mar 04; 16(3):1327-1339. PubMed ID: 30669846
    [Abstract] [Full Text] [Related]

  • 3. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS, Taylor LS.
    Pharm Res; 2017 Dec 04; 34(12):2842-2861. PubMed ID: 28956218
    [Abstract] [Full Text] [Related]

  • 4. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
    Indulkar AS, Lou X, Zhang GGZ, Taylor LS.
    Pharm Res; 2022 Feb 04; 39(2):381-397. PubMed ID: 35169959
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of surfactants in improving release from higher drug loading amorphous solid dispersions.
    Correa-Soto CE, Gao Y, Indulkar AS, Zhang GGZ, Taylor LS.
    Int J Pharm; 2022 Sep 25; 625():122120. PubMed ID: 35987321
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide.
    Zhang HJ, Chiang CW, Maschmeyer-Tombs T, Conklin B, Napolitano JG, Lubach JW, Nagapudi K, Mao C, Chen Y.
    Mol Pharm; 2024 Jul 01; 21(7):3395-3406. PubMed ID: 38836777
    [Abstract] [Full Text] [Related]

  • 15. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S, Kestur US, Flaherty DP, Taylor LS.
    Mol Pharm; 2020 Apr 06; 17(4):1261-1275. PubMed ID: 32134677
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N, Cape JL, Mankani BR, Zemlyanov DY, Shepard KB, Morgen MM, Taylor LS.
    Mol Pharm; 2020 Oct 05; 17(10):4004-4017. PubMed ID: 32931293
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced Dissolution of Amphotericin B through Development of Amorphous Solid Dispersions Containing Polymer and Surfactants.
    Smith-Craven MM, Dening TJ, Basra AK, Hageman MJ.
    J Pharm Sci; 2024 Aug 05; 113(8):2454-2463. PubMed ID: 38701896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.